Ask AI

Maintaining Vaccine Access When Recommendations Differ

Clinical Thought
Clinical Thought Start Activity

Released: November 19, 2026

See Activity Collection

Evidence-based vaccine coverage is important, but the policies and workflows used to implement it ultimately determine whether patients receive appropriate vaccination. Two issues that managed care organizations and pharmacy teams continue to face are which recommendations we should follow and how we make sure those recommendations translate into patient care. Read on to learn what I think managed care pharmacy teams can do to make sure coverage policies and pharmacy operations support vaccination.

Maintaining Vaccine Access

The questions after our discussion on vaccine uptake at a recent webinar for managed care organizations and pharmacy teams highlighted 2 issues they continue to face: which recommendations we should follow and how we make sure those recommendations translate into patient care. They are related concerns, but not the same.

Which Recommendations Should We Follow?
CDC recommendations remain an important starting point and help establish federal coverage requirements. However, I would also review the available evidence, recommendations from professional medical societies, and applicable state requirements. Recent changes involving the US Advisory Committee on Immunization Practices (ACIP) and the resulting legal challenges have created uncertainty. My hope is that we return to a transparent, consistent process for evaluating vaccine evidence, but in the meantime, plans need a way to make sound clinical decisions.

Under the Affordable Care Act, applicable ACIP recommendations establish minimum no-cost-sharing coverage requirements for nongrandfathered private plans. That does not prevent payers from choosing broader vaccine coverage, consistent with plan design and applicable law. For vaccines supported by professional society recommendations, a plan can choose to cover them without first requiring a denial or prior authorization. If that is the coverage intent, pharmacy and medical benefits, eligibility criteria, and claims edits should reflect it. If a patient at the pharmacy counter is told that a vaccine claim will not process, they may not return, even if the rejection was unintended.

Making Vaccine Assessment a Shared Responsibility
A common concern in many pharmacy settings, including retail, is how to balance vaccination goals with the time needed to verify histories and identify unmet needs. Having worked in community pharmacy, I understand the pressure to meet operational targets. But counting doses administered alone does not tell us whether the appropriate patients are being vaccinated or whether we are missing opportunities.

When appropriate, pharmacy leaders can incorporate standardized assessment steps, make immunization registry information easier to retrieve, and use technicians to help gather histories. Health plans and pharmacy benefit managers can support those efforts through timely data sharing, clear coverage information, and measures that recognize appropriate vaccination and series completion rather than volume alone. If we expect pharmacists to provide clinical care, the workflow needs to support that responsibility.

What About the Cost of Vaccination?
The costs have been evaluated, although not as one figure for every vaccine across every age group. In a CDC analysis of US children born during 1994-2023, estimated direct immunization program costs were $240 billion, compared with $780 billion in direct costs averted. That represents $540 billion in net direct savings. Net societal savings, which account for broader consequences, were approximately $2.7 trillion. Of importance, these modeled savings already account for the costs of vaccination.

We have strong evidence that vaccination provides clinical and economic value. Our challenge is making sure coverage policies and pharmacy operations allow that value to be realized.

Your Thoughts
What changes would most improve the ability of pharmacy teams to assess and address vaccination gaps? Leave a comment to join the discussion!